BCDA RSI Chart
Last 30 days
8.1%
Last 90 days
-11.1%
Trailing 12 Months
-76.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 468.0K | 0 | 0 | 0 |
2023 | 1.4M | 425.0K | 570.0K | 477.0K |
2022 | 1.1M | 1.2M | 1.3M | 1.4M |
2021 | 153.0K | 195.0K | 982.0K | 1.0M |
2020 | 532.5K | 473.5K | 313.5K | 145.0K |
2019 | 642.0K | 489.0K | 599.0K | 710.5K |
2018 | 541.0K | 668.0K | 622.0K | 625.0K |
2017 | 535.0K | 503.0K | 516.0K | 479.0K |
2016 | 946.0K | 965.0K | 961.0K | 576.0K |
2015 | 465.0K | 485.0K | 510.0K | 904.0K |
2014 | 328.0K | 364.0K | 389.0K | 427.0K |
2013 | 89.0K | 141.0K | 193.0K | 268.0K |
2012 | 24.5K | 37.0K | 49.5K | 62.0K |
2011 | 0 | 0 | 0 | 12.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 19, 2024 | frost phillip md et al | sold | -55,814 | 0.43 | -129,802 | - |
Dec 16, 2022 | frost phillip md et al | bought | 1,000,000 | 1.68 | 595,238 | - |
Aug 06, 2019 | stertzer simon h | acquired | 202,452 | 3.00 | 67,484 | - |
Aug 02, 2019 | stertzer simon h | bought | 999,996 | 6.00 | 166,666 | - |
Jun 28, 2019 | altman peter | bought | 5,223 | 8.705 | 600 | president and ceo |
Jun 26, 2019 | altman peter | bought | 924 | 9.24 | 100 | president and ceo |
Jun 25, 2019 | altman peter | bought | 5,423 | 10.846 | 500 | president and ceo |
Jun 24, 2019 | altman peter | bought | 1,094 | 10.945 | 100 | president and ceo |
Jun 20, 2019 | altman peter | bought | 2,700 | 9.00 | 300 | president and ceo |
Jun 19, 2019 | altman peter | bought | 4,532 | 11.33 | 400 | president and ceo |
Which funds bought or sold BCDA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | unchanged | - | -5,401 | 8,547 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -4.48 | 93.00 | 667 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -49.33 | - | - | -% |
May 15, 2024 | WEDBUSH SECURITIES INC | unchanged | - | -4,000 | 6,000 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 45,209 | 45,209 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 29.58 | -32.00 | 127 | -% |
May 15, 2024 | Family Management Corp | unchanged | - | -19,933 | 31,543 | 0.01% |
May 15, 2024 | Scientech Research LLC | sold off | -100 | -14,863 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -0.24 | -1,688 | 2,657 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | 17.00 | 86.00 | -% |
Unveiling BioCardia Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to BioCardia Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
BioCardia Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 323.1% | 55.00 | 13.00 | 357 | 43.00 | 64.00 | 106 | 212 | 974 | 527 | 79.00 | 821 | 69.00 | 46.00 | 46.00 | 34.00 | 27.00 | 38.00 | 215 | 194 | 86.00 | 216 |
Costs and Expenses | 11.1% | 2,330 | 2,097 | 2,955 | 3,495 | 3,574 | 3,124 | 3,272 | 3,470 | 3,387 | 3,540 | 3,529 | 3,558 | 3,018 | 3,544 | 3,882 | 3,601 | 4,647 | 3,751 | 3,421 | 3,848 | 3,903 |
S&GA Expenses | 15.7% | 1,089 | 941 | 1,083 | 1,181 | 1,190 | 924 | 1,128 | 1,166 | 1,201 | 1,425 | 1,289 | 1,196 | 1,177 | 1,219 | 1,408 | 1,377 | 1,857 | 1,544 | 1,390 | 1,438 | 1,631 |
R&D Expenses | 7.4% | 1,241 | 1,156 | 1,872 | 2,314 | 2,384 | 2,200 | 2,144 | 2,304 | 2,186 | 2,115 | 2,240 | 2,362 | 1,841 | 2,325 | 2,474 | 2,224 | 2,786 | 2,170 | 2,007 | 2,219 | 2,166 |
EBITDA Margin | 1.9% | 11.64* | 11.43* | 9.57* | 12.85* | 4.02* | 4.03* | 4.29* | 4.59* | 4.94* | 5.35* | 5.64* | 28.43* | 36.22* | 38.28* | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | - | - | - | 112 | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | 1.9% | 11.47* | 11.25* | 9.42* | 12.63* | 3.96* | 3.97* | 4.23* | 4.54* | 4.88* | 5.29* | 5.47* | 27.53* | 35.08* | 37.02* | - | - | - | - | - | - | - |
Net Income | -9.4% | -2,267 | -2,072 | -2,574 | -3,424 | -3,501 | -3,028 | -3,057 | -2,497 | -3,325 | -3,461 | -2,706 | -3,487 | -2,969 | -2,989 | -3,848 | -3,573 | -4,594 | -3,501 | -3,792 | -3,750 | -3,665 |
Net Income Margin | 8.9% | -22.09* | -24.26* | -21.98* | -30.61* | -8.91* | -8.81* | -9.73* | -10.13* | -11.81* | -12.44* | -12.37* | -68.17* | -87.44* | -103.48* | - | - | - | - | - | - | - |
Free Cashflow | 17.3% | -1,530 | -1,851 | -2,412 | -3,153 | -2,570 | -2,999 | -2,020 | -2,670 | -2,942 | -3,016 | -2,663 | -2,893 | -1,910 | -3,417 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.3% | 2,679 | 2,987 | 3,747 | 6,389 | 7,128 | 9,793 | 9,179 | 11,266 | 12,840 | 15,718 | 17,330 | 20,218 | 23,308 | 23,424 | 9,502 | 13,128 | 4,384 | 7,678 | 10,681 | 2,716 | 5,157 |
Current Assets | -13.8% | 1,259 | 1,461 | 2,116 | 4,650 | 5,289 | 7,864 | 7,154 | 9,152 | 10,661 | 13,481 | 17,006 | 19,741 | 22,659 | 22,658 | 8,590 | 12,096 | 3,219 | 6,378 | 9,237 | 1,152 | 3,528 |
Cash Equivalents | -13.7% | 949 | 1,100 | 1,835 | 4,305 | 4,857 | 7,363 | 6,667 | 8,614 | 6,700 | 12,872 | 15,900 | 18,543 | 21,502 | 21,407 | 7,392 | 11,086 | 2,587 | 5,585 | 8,910 | 517 | 2,838 |
Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.00 | 45.00 | 5.00 | 118 |
Net PPE | -20.2% | 75.00 | 94.00 | 114 | 139 | 158 | 170 | 189 | 204 | 195 | 182 | 175 | 184 | 164 | 145 | 161 | 154 | 164 | 181 | 210 | 218 | 175 |
Liabilities | 7.9% | 4,954 | 4,590 | 4,407 | 4,754 | 5,228 | 4,901 | 5,082 | 4,532 | 5,471 | 5,343 | 3,918 | 4,545 | 4,746 | 4,248 | 5,389 | 5,837 | 5,667 | 5,308 | 5,487 | 4,952 | 4,339 |
Current Liabilities | 12.8% | 4,071 | 3,608 | 3,330 | 3,616 | 4,000 | 3,585 | 3,684 | 3,054 | 3,913 | 3,712 | - | - | - | 4,248 | 4,320 | 4,551 | 4,510 | 4,003 | 4,044 | 4,066 | 3,323 |
Shareholder's Equity | -41.9% | -2,275 | -1,603 | - | 1,635 | 1,900 | 4,892 | 4,097 | 6,734 | 7,369 | 10,375 | 13,412 | 15,673 | 18,562 | 19,176 | 4,113 | 7,291 | - | 2,370 | 5,194 | - | 818 |
Retained Earnings | -1.5% | -154,400 | -152,175 | -150,103 | -147,500 | -144,105 | -140,604 | -137,576 | -134,500 | 137,600 | -128,697 | -125,200 | -122,530 | -119,043 | -116,074 | -113,085 | -109,237 | -105,664 | -101,070 | -97,568 | -93,776 | -90,026 |
Additional Paid-In Capital | 1.1% | 152,140 | 150,548 | 149,421 | 149,142 | 145,985 | 145,476 | 141,655 | 141,235 | 139,374 | 139,055 | 138,631 | 138,186 | 137,588 | 135,234 | 117,186 | 116,516 | 104,374 | 103,433 | 102,716 | 91,496 | 90,800 |
Shares Outstanding | 13.0% | 26,733 | 23,667 | 21,619 | 21,586 | 20,202 | 17,721 | 17,845 | 17,652 | 17,066 | 16,918 | 16,868 | 17,047 | 16,569 | 16,297 | - | - | - | - | - | - | - |
Float | - | - | - | - | 48,000 | - | - | - | 19,800 | - | - | - | 51,800 | - | - | - | 20,600 | - | - | - | 23,227 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 17.3% | -1,530 | -1,851 | -2,412 | -3,151 | -2,560 | -2,997 | -2,006 | -2,645 | -2,913 | -2,975 | -2,643 | -2,865 | -1,883 | -3,417 | -3,604 | -2,343 | -2,993 | -3,256 | -1,472 | -2,252 | -2,465 |
Share Based Compensation | 10.9% | 204 | 184 | 251 | 317 | 278 | 280 | 280 | 304 | 319 | 424 | 437 | 384 | 416 | 619 | 737 | 655 | 941 | 580 | 756 | 696 | 690 |
Cashflow From Investing | - | - | - | - | -2.00 | -10.00 | -2.00 | -14.00 | -25.00 | -29.00 | -41.00 | -20.00 | -28.00 | -27.00 | - | -23.00 | -4.00 | -5.00 | -2.00 | -20.00 | -69.00 | -55.00 |
Cashflow From Financing | 23.0% | 1,376 | 1,119 | -58.00 | 2,601 | 64.00 | 3,695 | 73.00 | 1,354 | - | - | 8.00 | -66.00 | 2,005 | 17,432 | -67.00 | - | - | -67.00 | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue, Product and Service [Extensible Enumeration] | Collaboration Agreement [Member] | Collaboration Agreement [Member] |
Total revenue | $ 55 | $ 64 |
Research and development | 1,241 | 2,384 |
Selling, general and administrative | 1,089 | 1,190 |
Total costs and expenses | 2,330 | 3,574 |
Operating loss | (2,275) | (3,510) |
Total other income, net | 8 | 9 |
Net loss | $ (2,267) | $ (3,501) |
Net loss per share, basic and diluted (in dollars per share) | $ (0.09) | $ (0.17) |
Weighted-average shares used in computing net loss per share, basic and diluted (in shares) | 25,133,093 | 20,177,167 |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Cash and cash equivalents | $ 949,000 | $ 1,103,000 |
Accounts receivable, net of allowance for doubtful accounts of $22 and $11 as of September 30, 2023 and December 31, 2022, respectively | 58,000 | 63,000 |
Prepaid expenses and other current assets | 252,000 | 295,000 |
Total current assets | 1,259,000 | 1,461,000 |
Property and equipment, net | 75,000 | 94,000 |
Operating lease right-of-use asset, net | 1,174,000 | 1,261,000 |
Other assets | 171,000 | 171,000 |
Total assets | 2,679,000 | 2,987,000 |
Accounts payable | 1,030,000 | 890,000 |
Accrued expenses and other current liabilities | 2,696,000 | 2,385,000 |
Operating lease liability - current | 345,000 | 333,000 |
Total current liabilities | 4,071,000 | 3,608,000 |
Operating lease liability - noncurrent | 883,000 | 982,000 |
Total liabilities | 4,954,000 | 4,590,000 |
Commitments and Contingencies | ||
Preferred stock, $0.001 par value, 25,000,000 shares authorized and no shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.001 par value, 100,000,000 shares authorized, 26,836,389 and 23,666,534 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 27,000 | 24,000 |
Additional paid-in capital | 152,140,000 | 150,548,000 |
Accumulated deficit | (154,442,000) | (152,175,000) |
Total stockholders’ equity (deficit) | (2,275,000) | (1,603,000) |
Total liabilities and stockholders’ equity (deficit) | $ 2,679,000 | $ 2,987,000 |